"In spinal cord injury, Neuralstem expects the first patient to be treated in the U.S. in the next few months. Neuralstem is currently finalizing IRB approval. Keith Tansey, MD, PhD of the Shepherd Center has been announced as the principal investigator, and the surgeries will be done at the University of California, San Diego. The trial protocol calls for enrollment of eight patients with T2-T12 complete thoracic injury (ASIA-A complete paralysis) one-to-two years post-injury. Patients will get six injections of NSI-566, with the first four patients getting 100,000 cells per injection followed by the next four patients getting 200,000 cells per injection. The primary endpoint is safety and toxicity, but secondary measures will include graft survival measured by MRI, ASIA level, SCI motor function level, sensory and evoked index measures, and things like bowel and bladder function. Neuralstem plans a second spinal cord injury trial in Seoul, South Korea with partner, CJ CheilJedang, in acute injured patients, which will start during the first half of 2014."
It would be nice if this showed some promise, to be honest I really don't understand all this stemcell stuff, that's why I don't comment much on it, but I really hope something works and in the near future.
Anyone interested, check out Aprils blog heres the link aprilals.com/about/. She's one of the patients in Nueralstems trial. Sent shivers up my back while reading about her diagnosis and lack of any treatment options. She has received stem cells, check it out.